This inventor holds 1 USPTO granted patent. Top assignee: Institut Francais De Recherche Scientifique Pour Le Developpment En. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Mind of Jean Charles Gantier
Introduction
Jean Charles Gantier, an accomplished inventor based in Chatenay Malabry, France, has contributed significantly to the field of scientific research. With a keen focus on developing treatments for infectious diseases, Gantier's innovative spirit is exemplified through his patented work, showcasing his dedication to advancing medical science.
Latest Patents
Among his notable achievements, Jean Charles Gantier holds a patent for "2-substituted quinolines for the treatment of leishmaniasis." This invention highlights his commitment to finding solutions for leishmaniasis, a disease that poses serious health risks in various regions of the world.
Career Highlights
Gantier works at the Institut Français de Recherche Scientifique pour le Développement (IRD), a prominent research institution dedicated to scientific advancement and humanitarian efforts. His role at IRD underscores his involvement in innovative research that seeks to improve health outcomes and address pressing global health issues.
Collaborations
Throughout his career, Gantier has collaborated with esteemed colleagues, including Alain Fournet and Alcira Angelo Barrios. These partnerships foster an environment of creativity and teamwork, leading to groundbreaking discoveries and innovations in their respective fields.
Conclusion
Jean Charles Gantier exemplifies the qualities of an inspiring inventor, dedicated to making a difference through his work. With a patent to his name and a commitment to collaboration in research, he continues to contribute to the ongoing fight against diseases like leishmaniasis, showcasing the vital role inventors play in advancing public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile